Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$12.53 USD
+0.16 (1.29%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.51 -0.02 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LQDA 12.53 +0.16(1.29%)
Will LQDA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LQDA
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
Other News for LQDA
Commit To Purchase Liquidia Corp At $7.50, Earn 15.5% Annualized Using Options
Commit To Buy Liquidia Corp At $10, Earn 28% Annualized Using Options
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
Buy Rating for Liquidia Technologies: Innovation and Market Potential Drive Strong Investment Case
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference